Free Trial

Ascendant Resources (ASND) Competitors

Ascendant Resources logo
C$0.05 0.00 (0.00%)
(As of 11:26 AM ET)

ASND vs. ZOM, CGC, ACST, AEZS, RGC, NEPT, DBV, NBY, NVV, and RTI

Should you be buying Ascendant Resources stock or one of its competitors? The main competitors of Ascendant Resources include Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), Canadian Gold (CGC), Acasti Pharma (ACST), Aeterna Zentaris (AEZS), Relevant Gold (RGC), Neptune Wellness Solutions (NEPT), Doubleview Capital (DBV), Niobay Metals (NBY), Norvista Capital (NVV), and Radient Technologies (RTI). These companies are all part of the "pharmaceutical products" industry.

Ascendant Resources vs.

Ascendant Resources (TSE:ASND) and Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOM) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and risk.

14.5% of Ascendant Resources shares are held by institutional investors. 3.3% of Ascendant Resources shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Ascendant Resources received 47 more outperform votes than Zomedica Pharmaceuticals Corp. (ZOM.V) when rated by MarketBeat users. However, 78.33% of users gave Zomedica Pharmaceuticals Corp. (ZOM.V) an outperform vote while only 62.67% of users gave Ascendant Resources an outperform vote.

CompanyUnderperformOutperform
Ascendant ResourcesOutperform Votes
94
62.67%
Underperform Votes
56
37.33%
Zomedica Pharmaceuticals Corp. (ZOM.V)Outperform Votes
47
78.33%
Underperform Votes
13
21.67%

Zomedica Pharmaceuticals Corp. (ZOM.V) has lower revenue, but higher earnings than Ascendant Resources. Zomedica Pharmaceuticals Corp. (ZOM.V) is trading at a lower price-to-earnings ratio than Ascendant Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ascendant ResourcesC$77.82M0.12-C$4.75M-C$0.03-1.67
Zomedica Pharmaceuticals Corp. (ZOM.V)N/AN/AN/A-C$0.11-2.61

Ascendant Resources' return on equity of 230.96% beat Zomedica Pharmaceuticals Corp. (ZOM.V)'s return on equity.

Company Net Margins Return on Equity Return on Assets
Ascendant ResourcesN/A 230.96% -12.94%
Zomedica Pharmaceuticals Corp. (ZOM.V) N/A N/A N/A

In the previous week, Ascendant Resources had 2 more articles in the media than Zomedica Pharmaceuticals Corp. (ZOM.V). MarketBeat recorded 2 mentions for Ascendant Resources and 0 mentions for Zomedica Pharmaceuticals Corp. (ZOM.V). Ascendant Resources' average media sentiment score of 0.84 beat Zomedica Pharmaceuticals Corp. (ZOM.V)'s score of 0.00 indicating that Ascendant Resources is being referred to more favorably in the media.

Company Overall Sentiment
Ascendant Resources Positive
Zomedica Pharmaceuticals Corp. (ZOM.V) Neutral

Summary

Ascendant Resources beats Zomedica Pharmaceuticals Corp. (ZOM.V) on 9 of the 11 factors compared between the two stocks.

Get Ascendant Resources News Delivered to You Automatically

Sign up to receive the latest news and ratings for ASND and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ASND vs. The Competition

MetricAscendant ResourcesOther Industrial Metals & Mining IndustryMaterials SectorTSE Exchange
Market CapC$9.33MC$866.53MC$2.83BC$6.19B
Dividend Yield4.75%6.42%5.25%5.31%
P/E Ratio-1.6786.38112.4926.60
Price / Sales0.1251,786.87589,137.281,474.09
Price / Cash160.0024.3923.4282.35
Price / Book-0.502.533.323.13
Net Income-C$4.75MC$55.64MC$148.77MC$292.70M
7 Day PerformanceN/A1.07%0.88%1.32%
1 Month PerformanceN/A-4.65%1.59%13.16%
1 Year PerformanceN/A32.75%27.50%44.29%

Ascendant Resources Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ASND
Ascendant Resources
0.9402 of 5 stars
C$0.05
flat
C$0.30
+500.0%
-44.4%C$9.33MC$77.82M-1.67640
ZOM
Zomedica Pharmaceuticals Corp. (ZOM.V)
N/AC$0.29
-6.6%
N/A+0.0%C$36.73MN/A-2.6150Gap Down
CGC
Canadian Gold
N/AC$0.15
flat
N/A-9.1%C$27.80MC$36.51M-5.003,150News Coverage
ACST
Acasti Pharma
N/AC$0.58
+1.8%
N/A+0.0%C$25.87MC$115,000.00-1.0732
AEZS
Aeterna Zentaris
N/AN/AN/AN/AC$25.37MC$2.37M-2.6120
RGC
Relevant Gold
N/AC$0.29
flat
N/A+87.1%C$21.65MN/A-4.1410Gap Up
NEPT
Neptune Wellness Solutions
N/AN/AN/AN/AC$15.73MC$48.80M-0.08130Gap Down
DBV
Doubleview Capital
N/AC$0.08
+7.1%
N/A+0.0%C$8.62MN/A-37.5080Gap Up
NBY
Niobay Metals
N/AC$0.07
+16.7%
N/A+16.7%C$7.22MN/A-2.3330Gap Up
NVV
Norvista Capital
N/AC$0.08
-6.3%
N/A+0.0%C$5.26MC$-1,274,069.00-1.631,990Gap Down
RTI
Radient Technologies
N/AC$0.01
flat
N/A+0.0%C$2.70MC$3.15M-0.25500High Trading Volume

Related Companies and Tools


This page (TSE:ASND) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners